86
Views
4
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Biological vascular grafts for hemodialysis access

, , &
Pages 171-175 | Published online: 09 Jan 2014

References

  • Akoh JA. Prosthetic arteriovenous grafts for hemodialysis. J. Vasc. Access 10(3), 137–147 (2009).
  • McAllister TN, Maruszewski M, Garrido SA et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373(9673), 1440–1446 (2009).
  • Tillman BW, Yazdani SK, Neff LP et al. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture. J. Vasc. Surg. 56(3), 783–793 (2012).
  • Tillman BW, Yazdani SK, Geary RL, Corriere MA, Atala A, Yoo JJ. Efficient recovery of endothelial progenitors for clinical translation. Tissue Eng. Part C Methods 15(2), 213–221 (2009).
  • Yazdani SK, Tillman BW, Berry JL, Soker S, Geary RL. The fate of an endothelium layer after preconditioning. J. Vasc. Surg. 51(1), 174–183 (2010).
  • Matsuura JH, Black KS, Levitt AB et al. Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model. J. Am. Coll. Surg. 198(5), 778–783 (2004).
  • Spark JI, Yeluri S, Derham C, Wong YT, Leitch D. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br. J. Surg. 95(5), 582–585 (2008).
  • Morosetti M, Cipriani S, Dominijanni S, Pisani G, Frattarelli D, Bruno F. Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis. J. Vasc. Surg. 54(6), 1713–1719 (2011).
  • Yates PJ. Regarding ‘Basilic vein transposition versus biosynthetic prosthesis as vascular access for hemodialysis’. J. Vasc. Surg. 55(3), 892; author reply 892–893 (2012).
  • Thum T, Hoeber S, Froese S et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ. Res. 100(3), 434–443 (2007).
  • Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231(4736), 397–400 (1986).
  • L’Heureux N, Pâquet S, Labbé R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J. 12(1), 47–56 (1998).
  • Niklason LE. Techview: medical technology. Replacement arteries made to order. Science 286(5444), 1493–1494 (1999).
  • Battisti G, Stio F, Marigliani M. The biosynthetic Omniflow prosthesis: preliminary experience. Ann. Ital. Chir. 60(5), 431–433 (1989).
  • Palumbo R, Niscola P, Calabria S et al. Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron. Clin. Pract. 113(2), c76–c80 (2009).
  • Brems J, Castaneda M, Garvin PJ. A five-year experience with the bovine heterograft for vascular access. Arch. Surg. 121(8), 941–944 (1986).
  • Heintjes RJ, Eikelboom BC, Steijling JJ et al. The results of denatured homologous vein grafts as conduits for secondary haemodialysis access surgery. Eur. J. Vasc. Endovasc. Surg. 9(1), 58–63 (1995).
  • Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J. Am. Coll. Surg. 201(2), 223–230 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.